The role of IL-10 in genetic susceptibility to coccidioidomycosis on mice

被引:7
|
作者
Fierer, Joshua [1 ]
机构
[1] VA Healthcare San Diego, Div Infect Dis, San Diego, CA 92161 USA
关键词
interleukin; nitric oxide; fungus;
D O I
10.1196/annals.1406.048
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Epidemiological and clinical studies have confirmed that coccidioidomycosis is more severe in African American and Filipino patients than in Caucasians, suggesting a genetic basis for susceptibility in humans. We discovered that inbred strains of mice also vary greatly in their susceptibility to Coccidioides immitis infections, and although resistance is the dominant phenotype, it is a multigenic trait in mice. We found a strong direct correlation between susceptibility in mice and the amount of IL-10 made in response to infection. We then showed that IL-10-deficient mice are much more resistant to infection than the parent C57BL/6 strain. Finally, we showed that genetically resistant mice that are transgenic for IL-10 and so overproduce that cytokine are more susceptible to C. immitis. This is in part due to suppression of NOS2 expression by IL-10.
引用
收藏
页码:236 / 244
页数:9
相关论文
共 50 条
  • [41] Genetic variants of IL-10 promoter influence susceptibility to HIV-1 infection and disease progression in the Polish population IL-10 polymorphisms and HIV-1
    Bratosiewicz-Wasik, Jolanta
    Wasik, Tomasz J.
    HUMAN IMMUNOLOGY, 2024, 85 (05)
  • [42] Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production
    Collins Ouma
    Gregory C. Davenport
    Tom Were
    Michael F. Otieno
    James B. Hittner
    John M. Vulule
    Jeremy Martinson
    John M. Ong’echa
    Robert E. Ferrell
    Douglas J. Perkins
    Human Genetics, 2008, 124 : 515 - 524
  • [43] Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production
    Ouma, Collins
    Davenport, Gregory C.
    Were, Tom
    Otieno, Michael F.
    Hittner, James B.
    Vulule, John M.
    Martinson, Jeremy
    Ong'echa, John M.
    Ferrell, Robert E.
    Perkins, Douglas J.
    HUMAN GENETICS, 2008, 124 (05) : 515 - 524
  • [44] Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice
    Sheil, B
    MacSharry, J
    O'Callaghan, L
    O'Riordan, A
    Waters, A
    Morgan, J
    Collins, JK
    O'Mahony, L
    Shanahan, F
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 144 (02): : 273 - 280
  • [45] IL-10 and IL-10 receptor defects in humans
    Glocker, Erik-Oliver
    Kotlarz, Daniel
    Klein, Christoph
    Shah, Neil
    Grimbacher, Bodo
    YEAR IN HUMAN AND MEDICAL GENETICS: INBORN ERRORS OF IMMUNITY II, 2011, 1246 : 102 - 107
  • [46] The Regulatory Role of IL-10 in Neurodegenerative Diseases
    Porro, Chiara
    Cianciulli, Antonia
    Panaro, Maria Antonietta
    BIOMOLECULES, 2020, 10 (07) : 1 - 15
  • [47] Vascular IL-10: a protective role in preeclampsia
    Kalkunte, Satyan
    Nevers, Tania
    Norris, Wendy E.
    Sharma, Surendra
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2011, 88 (02) : 165 - 169
  • [48] The role of IL-10 in murine models of arthritis
    Finnegan, A
    Cao, YX
    Doodes, PD
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S56 - S57
  • [49] Role of IL-10 in the pathogenesis of dengue infections
    Malavige, G. N.
    Jeewandara, C.
    Alles, L.
    Gomes, L.
    Salimi, M.
    Jayaratne, S. D.
    Ogg, G. S.
    ALLERGY, 2013, 68 : 339 - 339
  • [50] Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma
    Czarneski, J
    Lin, YC
    Chong, S
    McCarthy, B
    Fernandes, H
    Parker, G
    Mansour, A
    Huppi, K
    Marti, GE
    Raveche, E
    LEUKEMIA, 2004, 18 (03) : 597 - 606